Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
AequoScreen Parental Cell Line, Gα16, HEK293 Cells
AequoScreen Parental Cell Line, Gα16, HEK293 Cells
Stable, recombinant AequoScreen® parental cell line expressing aequorin and Gα16 in HEK293 host cells.
| Feature | Specification |
|---|---|
| Application | Drug Discovery & Development |
| G-Alpha Coupling Protein | Gα16 |
| Special Ordering Information | Requires accepted Terms and Conditions. Additional agreement needed for commercial use. |
| Validation | Calcium Luminescence |
Stable, recombinant AequoScreen® parental cell line expressing aequorin and Gα16 in HEK293 host cells.
AequoScreen Parental Cell Line, Gα16, HEK293 Cells
AequoScreen Parental Cell Line, Gα16, HEK293 Cells
Product information
Overview
Revvity's AequoScreen parental cell lines are provided in two vials of frozen cells, each containing ∽2.5 x 106 cells. Detailed product information as well as recommended cell culture conditions and validation assay date are available each cell line.
AequoScreen technology is a generic GPCR technology that can be used with Gs, Gi, and Gq-coupled GPCRs and calcium coupled ion channels. Following receptor stimulation, increases in intracellular calcium enable measurement of resulting flash luminescence signal.
Revvity’s AequoScreen cell lines require accepted cell line Terms and Conditions prior to order processing. Additional agreement needed for commercial use. Please use link above to accept Terms and Conditions or to request an agreement for commercial use.
Specifications
| Application |
Drug Discovery & Development
|
|---|---|
| Brand |
AequoScreen
|
| G-Alpha Coupling Protein |
Gα16
|
| Host Cell Line |
HEK293
|
| Host Species |
Human
|
| Shipping Conditions |
Shipped in Dry Ice
|
| Special Ordering Information |
Requires accepted Terms and Conditions. Additional agreement needed for commercial use.
|
| Target Class |
GPCR
|
| Unit Size |
5 million
|
| Validation |
Calcium Luminescence
|
Loading...
How can we help you?
We are here to answer your questions.
